Literature DB >> 31664761

Occurrence of psoriasiform eruption during dupilumab therapy for adult atopic dermatitis: A case series.

Maddalena Napolitano1, Massimiliano Scalvenzi2, Gabriella Fabbrocini2, Eleonora Cinelli2, Cataldo Patruno3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31664761     DOI： 10.1111/dth.13142

Source DB:  PubMed          Journal:  Dermatol Ther        ISSN： 1396-0296            Impact factor:   2.851


× No keyword cloud information.
  5 in total

Review 1.  Dupilumab and COVID-19: What should we expect?

Authors:  Cataldo Patruno; Luca Stingeni; Gabriella Fabbrocini; Katharina Hansel; Maddalena Napolitano
Journal:  Dermatol Ther       Date:  2020-05-20       Impact factor: 2.851

2.  Pyoderma gangrenosum developing in a patient treated with dupilumab.

Authors:  Jessica Nasseh; Henry Abi Rached; Ioana Dumitru; Delphine Staumont-Sallé; Frédéric Dezoteux
Journal:  JAAD Case Rep       Date:  2021-12-17

Review 3.  A Literature Review of Real-World Effectiveness and Safety of Dupilumab for Atopic Dermatitis.

Authors:  Masahiro Kamata; Yayoi Tada
Journal:  JID Innov       Date:  2021-07-30

Review 4.  Pathogenesis of Paradoxical Reactions Associated with Targeted Biologic Agents for Inflammatory Skin Diseases.

Authors:  Fumi Miyagawa
Journal:  Biomedicines       Date:  2022-06-23

5.  Tumor Necrosis Factor Inhibitor-Induced Eczematous Eruption: A Report of Two Cases and Review of the Literature.

Authors:  Sohemi Pagan-Leon; Tyler Werbel; Marjorie Montanez-Wiscovich
Journal:  Cureus       Date:  2021-05-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.